Your body has already adapted once, so many people can escalate through the lower doses more quickly
Close monitoring is essential to safely initiating GLP-1 agonist treatment
the schedule shows minimum intervals and an ordered sequence, but the decision to hold, advance, or pause belongs to the clinician who knows your tolerability and goals
Barrile F, MKadmi C, De Francesco PN, Cabral A, Garca Romero G, Mustaf ER, et al
Currently, there is no robust evidence to suggest that GLP-1 receptor agonists directly impair thermoregulation through pharmacological action on temperature control centres in the hypothalamus
one of seven FDA-approved interchangeable biosimilars to ustekinumab (Stelara) Human interleukin (IL)-12 and -23 antagonist Indicated for adults with (1) moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy, (2) active psoriatic arthritis (PsA), (3) moderately to severely active Crohns disease (CD) and (4) moderately to severely active ulcerative colitis (UC)